BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9262653)

  • 1. Scientists to pursue AIDS vaccine based on EIA model.
    J Am Vet Med Assoc; 1997 Aug; 211(3):266. PubMed ID: 9262653
    [No Abstract]   [Full Text] [Related]  

  • 2. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
    Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
    Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of equine infectious anemia control and regulation in the United States.
    Knowles RC
    J Am Vet Med Assoc; 1984 Feb; 184(3):289-92. PubMed ID: 6321419
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine infectious anemia.
    Mod Vet Pract; 1974 Jan; 55(1):59-62 passim. PubMed ID: 4359480
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of equine infectious anemia in equids in southeastern United States.
    Loftin MK; Levine JF; McGinn T; Coggins L
    J Am Vet Med Assoc; 1990 Oct; 197(8):1018-20. PubMed ID: 2173692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.
    Craigo JK; Montelaro RC
    Viruses; 2013 Dec; 5(12):2963-76. PubMed ID: 24316675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.
    Meng Q; Lin Y; Ma J; Ma Y; Zhao L; Li S; Liang H; Zhou J; Shen R; Zhang X; Shao Y
    Arch Virol; 2011 Aug; 156(8):1455-62. PubMed ID: 21499906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein.
    Wang SZ; Rushlow KE; Issel CJ; Cook RF; Cook SJ; Raabe ML; Chong YH; Costa L; Montelaro RC
    Virology; 1994 Feb; 199(1):247-51. PubMed ID: 8116252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines.
    Montelaro RC; Grund C; Raabe M; Woodson B; Cook RF; Cook S; Issel CJ
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):413-5. PubMed ID: 8882322
    [No Abstract]   [Full Text] [Related]  

  • 15. A propagating epizootic of equine infectious anemia on a horse farm.
    Hall RF; Pursell AR; Cole JR; Youmans BC
    J Am Vet Med Assoc; 1988 Nov; 193(9):1082-4. PubMed ID: 2848789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression.
    Zhang X; Wang Y; Liang H; Wei L; Xiang W; Shen R; Shao Y
    J Gen Virol; 2007 Mar; 88(Pt 3):998-1004. PubMed ID: 17325374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic survey for equine infectious anemia virus in Louisiana.
    Issel CJ; Adams WV
    J Am Vet Med Assoc; 1979 Feb; 174(3):286-8. PubMed ID: 221447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine antibody to bovine serum induced by several equine vaccines as a source of extraneous precipitin lines in the agar gel immunodiffusion test for equine infectious anemia.
    Gaskin JM; Neal FC; Rubin HL
    Am J Vet Res; 1977 Mar; 38(3):373-7. PubMed ID: 192111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of horses against equine infectious anemia (EIA) with an attenuated EIA virus.
    Kono Y; Kobayashi K; Fukunaga Y
    Natl Inst Anim Health Q (Tokyo); 1970; 10(3):113-22. PubMed ID: 4320652
    [No Abstract]   [Full Text] [Related]  

  • 20. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
    Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
    Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.